Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Exchange Rate Effect: 2022-2025

Historic Exchange Rate Effect for Krystal Biotech (KRYS) over the last 3 years, with Sep 2025 value amounting to -$307,000.

  • Krystal Biotech's Exchange Rate Effect fell 207.34% to -$307,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $329,000, marking a year-over-year increase of 8325.00%. This contributed to the annual value of -$458,000 for FY2024, which is 193.59% down from last year.
  • Latest data reveals that Krystal Biotech reported Exchange Rate Effect of -$307,000 as of Q3 2025, which was down 128.99% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, Krystal Biotech's Exchange Rate Effect registered a high of $1.1 million during Q2 2025, and its lowest value of -$594,000 during Q4 2024.
  • In the last 3 years, Krystal Biotech's Exchange Rate Effect had a median value of $8,000 in 2023 and averaged $28,091.
  • Within the past 5 years, the most significant YoY rise in Krystal Biotech's Exchange Rate Effect was 2,283.33% (2024), while the steepest drop was 4,312.50% (2024).
  • Krystal Biotech's Exchange Rate Effect (Quarterly) stood at -$41,000 in 2022, then tumbled by 241.46% to -$140,000 in 2023, then plummeted by 324.29% to -$594,000 in 2024, then plummeted by 207.34% to -$307,000 in 2025.
  • Its Exchange Rate Effect stands at -$307,000 for Q3 2025, versus $1.1 million for Q2 2025 and $171,000 for Q1 2025.